Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension

Primary Pulmonary Hypertension

Rich, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., Detre, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,027

The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension

Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,558

Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)

Rubin, L. J., Mendoza, J., Hood, M., McGoon, M., Barst, R., Williams, W. B., Diehl, J. H., Crow, J., & Long, W. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-485 · Cited by 701

Increased plasma serotonin in primary pulmonary hypertension

Hervé, P., Launay, J., Scrobohaci, M.-L., Brenot, F., Simonneau, G., PETITPRETZ, P., Poubeau, P., Cerrina, J., Duroux, P., & Drouet, L. O. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80156-9 · Cited by 557

Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics

Hadengue, A., Benhayoun, M. K., Lebrec, D., & Benhamou, J. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90225-a · Cited by 497

Primary Pulmonary Hypertension and Cirrhosis: Are They Related?

McDonnell, P. J., Toye, P. A., & Hutchins, G. M. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.4.437 · Cited by 318

Primary Pulmonary Hypertension

Rubin, L. J. (1993) · CHEST Journal · doi:10.1378/chest.104.1.236 · Cited by 308

Primary pulmonary hypertension and fenfluramine use.

Brénot, F., Hervé, P., PETITPRETZ, P., Parent, F., Duroux, P., & Simonneau, G. (1993) · Heart · doi:10.1136/hrt.70.6.537 · Cited by 247

Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.

PETITPRETZ, P., Brénot, F., Azarian, R., Parent, F., Rain, B., Hervé, P., & Simonneau, G. (1994) · Circulation · doi:10.1161/01.cir.89.6.2722 · Cited by 238

Pulmonary hypertension and fenfluramine

Douglas, J. G., Munro, J., KITCHIN, A. H., Muir, A. L., & Proudfoot, A. T. (1981) · BMJ · doi:10.1136/bmj.283.6296.881 · Cited by 180

The Surgical Treatment of Morbid Obesity

Smith, D. M., Pories, W. J., & MacDonald, K. G. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-59651-3_11 · Cited by 25

Accelerated publication versus usual publication in 2 leading medical journals.

Ghali, W. A., Cornuz, J., McAlister, F. A., Wasserfallen, J., Devereaux, P. J., & Naylor, C. D. (2002) · Europe PMC (PubMed Central) · Cited by 24

Past and present of antiobesity agents: Focus on monoamine modulators

Khorassani, F., Misher, A. D., & Garris, S. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140034 · Cited by 26

A review of late-stage CNS drug candidates for the treatment of obesity

Heal, D. J., Gosden, J., & Smith, S. L. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.26 · Cited by 25

Nordexfenfluramine causes more severe pulmonary vasoconstriction than dexfenfluramine

Hong, Z., Olschewski, A., Reeve, H. L., Nelson, D. P., Hong, F., & Weir, Ε. K. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00247.2003 · Cited by 24

Prader–Willi syndrome

Couper, R. (1999) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.1999.00397.x · Cited by 24

Enhanced Hypoxic Pulmonary Vasoconstriction in Families of Adults or Children With Idiopathic Pulmonary Arterial Hypertension

Grünig, E., Dehnert, C., Mereles, D., Koehler, R., Olschewski, H., Bärtsch, P., & Janssen, B. J. (2005) · CHEST Journal · doi:10.1378/chest.128.6_suppl.630s-a · Cited by 24

Asymptomatic Mitral and Aortic Valve Disease Is Seen in Half of the Patients Taking ‘Phen-Fen'

Griffen, L., & Anchors, M. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.1.102 · Cited by 24

Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release

Kilpatrick, I. C., Traut, M., & Heal, D. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801732 · Cited by 24

Primary pulmonary hypertension: the pressure rises for a gene

Thomson, J. R., & Trembath, R. C. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.12.899 · Cited by 24

Appetite-Suppressant Drugs and Primary Pulmonary Hypertension

Schembre, D. B., & Boynton, K. K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360714 · Cited by 24

Analysis of Plasma Serotonin Levels and Hemodynamic Responses Following Chronic Serotonin Infusion in Broilers Challenged with Bacterial Lipopolysaccharide and Microparticles

Chapman, M. E., Taylor, R. L., & Wideman, R. F. (2007) · Poultry Science · doi:10.3382/ps.2007-00160 · Cited by 23

Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis

Damavandi, P. T., Fabin, N., Giossi, R., Matricardi, S., Giovane, C. D., Striano, P., Meletti, S., Brigo, F., Trinka, E., & Lattanzi, S. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00452-1 · Cited by 23

Impact of Weight-Loss Medications on the Cardiovascular System

Drolet, B., Simard, C., & Poirier, P. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707040-00005 · Cited by 23

Cilostazol Therapy Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat Model

Chang, L., Sun, C., Sheu, J., Chiang, C.-H., Youssef, A. A., Lee, F.-Y., Wu, C., & Yip, H. (2008) · Circulation Journal · doi:10.1253/circj.72.825 · Cited by 23

A close look at fenfluramine and dexfenfluramine

Vivero, L. E., Anderson, P. O., & Clark, R. F. (1998) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(97)00289-8 · Cited by 23

Insights into the Genetic and Molecular Basis of Primary Pulmonary Hypertension

Trembath, R. C., & Harrison, R. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000061565.22500.e7 · Cited by 23

THE TREATMENT OF OBESITY IN TYPE 2 DIABETES MELLITUS

Gumbiner, B. (1999) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70136-6 · Cited by 21

Treatments for severe pulmonary hypertension

Higenbottam, T., Stenmark, K. R., & Simonneau, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)00330-4 · Cited by 23

Autopsy Findings of Heart and Lungs in a Patient With Primary Pulmonary Hypertension Associated With Use of Fenfluramine and Phentermine

Tomita, T., & Zhao, Q. (2002) · CHEST Journal · doi:10.1378/chest.121.2.649 · Cited by 23

Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes

Frost, A., Zhao, C., Farber, H. W., Benza, R. L., Yen, J., Selej, M., & Elliott, C. G. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.007 · Cited by 22

2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery

Bender, A. M., Parr, L. C., Livingston, W. B., Lindsley, C., & Merryman, W. D. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01178 · Cited by 19

Medical management of obesity

Wechsler, J. G., & Leopold, K. (2003) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-003-0377-3 · Cited by 22

Sibutramine: possible cause of a reversible cardiomyopathy

Sayın, T., & Güldal, M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.060 · Cited by 22

PHARMACOTHERAPY FOR OBESITY

Hensrud, D. D. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70231-5 · Cited by 22

Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension

Rich, S., Shillington, A. C., & McLaughlin, V. V. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.08.034 · Cited by 22

A Critical Appraisal of the Updated 2014 Nice Pulmonary Hypertension Classification System

Lau, E., & Humbert, M. J. C. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.033 · Cited by 21

Therapeutic drug monitoring of fenfluramine in clinical practice: Pharmacokinetic variability and impact of concomitant antiseizure medications

Schoonjans, A., Roosens, L., Dewals, W., Paelinck, B. P., & Ceulemans, B. (2022) · Epilepsia · doi:10.1111/epi.17162 · Cited by 21

Platelet Serotonin Content and Transpulmonary Platelet Serotonin Gradient in Patients with Pulmonary Hypertension

Ulrich, S., Huber, L., Fischler, M., Treder, U., Maggiorini, M., Eberli, F. R., & Speich, R. (2010) · Respiration · doi:10.1159/000314271 · Cited by 21

Reducing the Risk of Obesity: Defining the Role of Weight Loss Drugs

Ling, H., Lenz, T. L., Burns, T. L., & Hilleman, D. E. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1277 · Cited by 21

Pulmonary arterial hypertension in four patients treated by leflunomide

Coirier, V., Lescoat, A., Chabanne, C., Fournet, M., Coiffier, G., Jouneau, S., Polard, É., & Jégo, P. (2018) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.12.014 · Cited by 21

The role of research evidence in pharmaceutical policy making: evidence when necessary but not necessarily evidence

Willison, D. J., & Sm, M. (1999) · Journal of Evaluation in Clinical Practice · doi:10.1046/j.1365-2753.1999.00193.x · Cited by 21

Pharmacoepidemiology

Garbe, E., & Suissa, S. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_31 · Cited by 22

Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la hipertensión arterial pulmonar

de Cardiología, G. D. T. D. L. S. E. (2005) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60732-9 · Cited by 21

Fluoxetine Is a Safer Alternative to Fenfluramine in the Medical Treatment of Obesity

Anchors, M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440320180027 · Cited by 21

Inhibition of Delayed Rectifier K+ Channels by Dexfenfluramine (Redux)

Hu, S., Wang, S., Gibson, J. C., & Gilbertson, T. A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37817-6 · Cited by 21

Effects of the sibutramine therapy on pulmonary artery pressure in obese patients

Guven, A., Koksal, N., Cetinkaya, A., Sokmen, G., & Ozdemir, R. (2004) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00314.x · Cited by 20

A Practical Approach of Pulmonary Hypertension in the Elderly

Hervé, P., & Lador, F. (2013) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0033-1356549 · Cited by 20

Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Management of Patients With Valvular Heart Disease): Developed in Collaboration With on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the A Report of the American College of Cardiology/American Heart Association Task Force ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease :

O’Gara, T., O’Rourke, R. A., Otto, C. M., Shah, P. M., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., Bonow, R. O., Carabello, B. A., et al. (2013) · Cited by 20

New targets for pulmonary arterial hypertension

Huertas, A., Tu, L., & Guignabert, C. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000404 · Cited by 23

Phentermine

Lim, S., Rogers, L. K., Tessler, O., Mundinger, G. S., Rogers, C. L., & Lau, F. H. (2018) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000001478 · Cited by 20

A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome

Schoonjans, A., & Ceulemans, B. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1877540 · Cited by 21

Animal models of pulmonary hypertension: Rho kinase inhibition

Firth, A. L., Choi, I., & Park, W. S. (2012) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2012.05.009 · Cited by 20

Imaging in pulmonary hypertension, part 2: large vessel diseases

McCann, C. A., Gopalan, D., Sheares, K. K. K., & Screaton, N. J. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130274 · Cited by 20

Pulmonary hypertension: From an orphan disease to a global epidemic

BUTROUS, G. S. (2020) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2020.5 · Cited by 20

Remodeling of the pulmonary artery induced by metastatic gastric carcinoma: a histopathological analysis of 51 autopsy cases

Ishiwatari, T., Okubo, Y., Tochigi, N., Wakayama, M., Nemoto, T., Kobayashi, J., Shinozaki, M., Aki, K., Sasai, D., Yamamoto, Y., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-14 · Cited by 20

Adverse effects of benfluorex on heart valves and pulmonary circulation

Szymanski, C., Andréjak, M., Peltier, M., Maréchaux, S., & Tribouilloy, C. M. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3642 · Cited by 20

Classification and epidemiology of pulmonary hypertension

McLaughlin, V. V. (2004) · Cardiology Clinics · doi:10.1016/j.ccl.2004.04.001 · Cited by 20

Bosentan: A novel agent for the treatment of pulmonary arterial hypertension

O’Callaghan, D. S., & Gaine, S. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.0098.x · Cited by 20

S -phenylpiracetam, a selective DAT inhibitor, reduces body weight gain without influencing locomotor activity

Zvejniece, L., Švalbe, B., Vavers, E., Makrecka‐Kuka, M., Makarova, E., Liepinsh, E., Kalvinsh, I., Liepinsh, E., & Dambrova, M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.07.009 · Cited by 19

Clinical aspects of portopulmonary hypertension

Medarov, B. I., Chopra, A., & Judson, M. A. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.04.004 · Cited by 19

Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway

Han, X., Chen, C., Cheng, G., Liang, L., Yao, X., Yang, G., You, P., & Shou, X. (2015) · Microvascular Research · doi:10.1016/j.mvr.2015.04.008 · Cited by 19

An Overview of Pulmonary Arterial Hypertension

Cheever, K. H. (2005) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200503000-00005 · Cited by 19

Appetite suppressants and pulmonary hypertension

Voelkel, N. F. (1997) · Thorax · doi:10.1136/thx.52.2008.s63 · Cited by 19

Introduction to the special issue: Fatness and temporality

Tidgwell, T., Friedman, M., Rinaldi, J., Kotow, C., & Lind, E. R. M. (2017) · Fat Studies · doi:10.1080/21604851.2017.1375262 · Cited by 19

Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons from Dravet Syndrome

Lersch, R., Jannadi, R., Grosse, L., Wagner, M., Schneider, M. F., von Stülpnagel, C., Heinen, F., Potschka, H., & Borggraefe, I. (2022) · The Neuroscientist · doi:10.1177/10738584221088244 · Cited by 20

EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase

Kandhi, S., Qin, J., Froogh, G., Jiang, H., Luo, M., Wolin, M. S., Huang, A., & Sun, D. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00208.2015 · Cited by 18

A Global Pulmonary Arterial Hypertension Registry: Is It Needed? Is It Feasible?

Gomberg‐Maitland, M., & Michelakis, E. D. (2010) · CHEST Journal · doi:10.1378/chest.09-3008 · Cited by 18

The Use of Antidepressants and the Risk of Idiopathic Pulmonary Arterial Hypertension

Fox, B. D., Azoulay, L., Dell’Aniello, S., Langleben, D., Lapi, F., Benisty, J. I., & Suissa, S. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.031 · Cited by 18

Idiopathic Pulmonary Arterial Hypertension and Its Prognosis in the Modern Management Era in Developed and Developing Countries

Jiang, X., Humbert, M. J. C., & Jing, Z. (2012) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000336068 · Cited by 18

Protein-induced satiation and the calcium-sensing receptor

Ojha, U. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s156597 · Cited by 18

Selective Serotonin Reuptake Inhibitors and Pulmonary Arterial Hypertension

Dhalla, I. A., Juurlink, D. N., Gomes, T., Granton, J. T., Zheng, H., & Mamdani, M. (2011) · CHEST Journal · doi:10.1378/chest.11-0426 · Cited by 18

Evaluation of the Serotonin Receptor Blockers Ketanserin and Methiothepin on the Pulmonary Hypertensive Responses of Broilers to Intravenously Infused Serotonin

Chapman, M. E., & Wideman, R. F., Jr. (2006) · Poultry Science · doi:10.1093/ps/85.4.777 · Cited by 18

Pathophysiology of Pulmonary Arterial Hypertension

Jain, S., Ventura, H. O., & deBoisblanc, B. (2007) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253207301732 · Cited by 18

Pharmacological and surgical treatments for obesity

DeWald, T. A., Khaodhiar, L., Donahue, M., & Blackburn, G. L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.007 · Cited by 19

Pulmonary hypertension and insulin resistance: a mechanistic overview

Zanotto, T. M., Gonçalves, A. E. D. S. S., & Saad, M. J. A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1283233 · Cited by 17

Current Therapeutic Approaches to Pulmonary Arterial Hypertension

Galiè, N., Palazzini, M., Leci, E., & Manes, A. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70145-6 · Cited by 18

The endothelium and genetics in pulmonary arterial hypertension

Nicod, L. P. (2007) · Swiss Medical Weekly · doi:10.4414/smw.2007.11668 · Cited by 17

Effective medical writing: How to write a case report which Editors would publish

Haq, R. U., & Dhammi, İ. K. (2017) · Indian Journal of Orthopaedics · doi:10.4103/ortho.ijortho_115_17 · Cited by 17

Disorders of Energy Balance

Lustig, R. H., & Weiss, R. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50024-7 · Cited by 17

Use of Anticoagulants in Patients with Pulmonary Hypertension

Bertoletti, L., Mismetti, V., & Giannakoulas, G. A. (2020) · Hämostaseologie · doi:10.1055/a-1171-3995 · Cited by 17

Current Pharmacological Treatment of Pulmonary Arterial Hypertension

Bouros, D. E., Steiropoulos, P., & Trakada, G. (2008) · Current Clinical Pharmacology · doi:10.2174/157488408783329887 · Cited by 17

Serotonin Transporter and Receptors in Various Forms of Human Pulmonary Hypertension

Marcos, É., Fadel, É., Sanchez, O., Humbert, M. J. C., Dartevelle, P., Simonneau, G., Hamon, M., Adnot, S., & Eddahibi, S. (2005) · CHEST Journal · doi:10.1378/chest.128.6_suppl.552s · Cited by 17

Diet and exercise in type 2 diabetes mellitus

Feuerstein, B. L., & Weinstock, R. S. (1997) · Nutrition · doi:10.1016/s0899-9007(96)00398-x · Cited by 17

To Treat or Not to Treat: That is the Question

Bray, G. A. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00586.x · Cited by 17

Primary Pulmonary Arterial Hypertension Presenting as Diffuse Micronodules on CT

Horton, M. R., & Tuder, R. M. (2004) · Critical Reviews in Diagnostic Imaging · doi:10.1080/10408370490888442 · Cited by 17

The Fenfluramine Metabolite (+)-Norfenfluramine Is Vasoactive

Ni, W., Li, M. W., Thakali, K. M., Fink, G. D., & Watts, S. W. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060806 · Cited by 17

Pulmonary hypertension related to drugs and toxins

Abenhaim, L., & Humbert, M. J. C. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199909000-00013 · Cited by 17

Adolescent obesity, a need for greater awareness and improved treatment

Trent, M., & Ludwig, D. S. (1999) · Current Opinion in Pediatrics · doi:10.1097/00008480-199908000-00005 · Cited by 17

Clinical Manifestation of HIV‐Related Pulmonary Hypertension

Petrosillo, N., Pellicelli, A. M., Boumis, E., & Ippolito, G. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03915.x · Cited by 17

Drug Therapy for Obesity in the Elderly

Dvorak, R. V., Starling, R. D., Calles-Escandón, J., Sims, E. A. H., & Poehlman, É. T. (1997) · Drugs & Aging · doi:10.2165/00002512-199711050-00002 · Cited by 17

Complex Vascular Lesions at Autopsy in a Patient With Phentermine-Fenfluramine Use and Rapidly Progressing Pulmonary Hypertension

Strother, J., Fedullo, P. F., Yi, E. S., & Masliah, E. (1999) · Archives of Pathology & Laboratory Medicine · doi:10.5858/1999-123-0539-cvlaai · Cited by 17

Outcomes of Pharmacological and Surgical Treatment for Obesity

Cerulli, J., & Malone, M. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814030-00004 · Cited by 17

Primary Pulmonary Hypertension and Anorectic Drugs

Louis, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400614 · Cited by 17

OBESITY

Aronne, L. J. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70599-x · Cited by 19

New and emerging pharmacologic treatments for developmental and epileptic encephalopathies

Vasquez, A., Buraniqi, E., & Wirrell, E. C. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001029 · Cited by 16

2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Hsu, C., Ho, W.-J., Huang, W.-C., Chiu, Y.-W., Hsu, T., Kuo, P., Hsu, H., Chang, J., Cheng, C., Lai, C., et al. (2014) · Europe PMC (PubMed Central) · Cited by 16

Analysis of the Drugs Withdrawn from the US Market from 1976 to 2010 for Safety Reasons

Rochelle, P. L., Lexchin, J., & Simonyan, D. (2016) · Pharmaceutical Medicine · doi:10.1007/s40290-016-0159-1 · Cited by 17

Role of Lipoxygenase Metabolites of Arachidonic Acid in Enhanced Pulmonary Artery Contractions of Female Rabbits

Pfister, S. L. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168716 · Cited by 16

Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study

Tribouilloy, C. M., Maréchaux, S., Jobic, Y., Jeu, A., Éderhy, S., Donal, E., Réant, P., Arnalsteen, E., Boulanger, J., Garban, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht266 · Cited by 16

Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease

Bazan, I. S., & Fares, W. H. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.02.049 · Cited by 16

In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension

Baumgart, B. R., Guha, M., Hennan, J. K., Li, J., Woicke, J., Simic, D., Graziano, M. J., Wallis, N., Sanderson, T. P., & Bunch, R. T. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3264-2 · Cited by 16

Primary Pulmonary Arterial Hypertension Presenting as Diffuse Micronodules on CT

Horton, M. R., & Tuder, R. M. (2004) · Critical reviews in computed tomography · doi:10.3109/10408370490888442 · Cited by 16

Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endothelial function in obese men

Watts, G. F. (2000) · QJM · doi:10.1093/qjmed/93.3.153 · Cited by 17

The Serotonin Pathway in Pulmonary Hypertension

Eddahibi, S., & Adnot, S. (2005) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-4.1.20 · Cited by 16

Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension

Charoenpong, P., Hall, N., Keller, C. M., Ram, A. K., Murnane, K. S., Goeders, N. E., Dhillon, N. K., & Walter, R. E. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.01.014 · Cited by 15

Dietary supplements for Lipedema

Bonetti, G., Herbst, K. L., Dhuli, K., Kiani, A. K., Michelini, S., Michelini, S., Ceccarini, M. R., Michelini, S., Ricci, M., Cestari, M., et al. (2022) · PubMed Central · doi:10.15167/2421-4248/jpmh2022.63.2s3.2758 · Cited by 17

Oral contraceptives and cardiovascular outcomes: cause or bias?

Spitzer, W. O. (2000) · Contraception · doi:10.1016/s0010-7824(00)00149-9 · Cited by 15

Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs

Grimaldi‐Bensouda, L., Rossignol, M., Danchin, N., Steg, P. G., Bessede, G., Ovize, M., Cottin, Y., Autret‐Leca, E., Bénichou, J., Abenhaim, L., et al. (2011) · Heart · doi:10.1136/hrt.2011.222448 · Cited by 15

HIV infection and pulmonary arterial hypertension

Cicalini, S., Chinello, P., & Petrosillo, N. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.10 · Cited by 15

Appetite suppressants and pulmonary hypertension

Voelkel, N. F. (1997) · Thorax · doi:10.1136/thx.52.2008.s63 · Cited by 19

Anorexigens and Pulmonary Hypertension in the United States

Rich, S., Rubin, L. J., Walker, A. M., Schneeweiß, S., & Abenhaim, L. (2000) · CHEST Journal · doi:10.1378/chest.117.3.870 · Cited by 190

Appetite suppressants and primary pulmonary hypertension in the United Kingdom.

Thomas, S. H. L., Butt, A. Y., Corris, P. A., Egan, J., Higenbottam, T., Madden, B. P., & WALLER, P. C. (1995) · Heart · doi:10.1136/hrt.74.6.660 · Cited by 36

High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium

Delcroix, M., Kurz, X., Walckiers, D., DEMEDTS, M. G., & Naeije, R. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12020271 · Cited by 37

Fenfluramines, Obesity and Primary Pulmonary Hypertension

Faich, G. A. (1996) · Elsevier eBooks · doi:10.1016/b978-012518170-9/50016-7